Ỷ LỆ PHỤ NỮ CHẤP NHẬN XÉT NGHIỆM HUMAN PAPILLOMAVIRUS KHI THỰC HIỆN TẦM SOÁT UNG THƯ CỔ TỬ CUNG TẠI BỆNH VIỆN TỪ DŨ

Abstract

Objective: To determine the acceptance rate of HPV testing during cervical cancer screening and associated factors among women attending the Gynecology Outpatient Department at Tu Du Hospital. Subjects and Methods: A cross-sectional descriptive study was conducted on 385 women aged 25 and above who had been sexually active and visited the Gynecology Outpatient Department of Tu Du Hospital between December 2024 and April 2025. The study assessed the acceptance rate of HPV testing during cervical cancer screening. Results: The acceptance rate for HPV testing during cervical cancer screening was 70.6% (95% CI: 66.2–75.1). Reasons for refusal included: never having heard of HPV or the HPV test before (35%), concerns about test cost (14.5%), fear of test results (14%), the misconception that screening is unnecessary without symptoms (17.8%) and lack of trust in the effectiveness of the test (18.7%). Factors associated with non-acceptance of HPV testing included: women who had first sexual intercourse after the age of 20 (OR=1.9, 95% CI: 1.1–2.9, p=0.012), women who had never heard of HPV testing (OR=2.1, 95% CI: 1.3–3.4, p=0.002), and women without any prior gynecological conditions (OR=1.9, 95% CI: 1.1–3.7, p=0.043). Conclusion: There is a need to improve counseling and public health communication strategies, particularly targeting women who have not previously been exposed to HPV-related information.